At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Stenting of common and/or external iliacsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries
In Brief
A clinical study evaluating Stenting of common and/or external iliacs for Common Iliac Artery Occlusive Disease and 2 related conditions. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The primary objective of the VBX13-05 clinical study is to evaluate the safety and efficacy of VIABAHN BX for the treatment of arterial occlusive disease in patients with de novo or restenotic lesions in the common and/or external iliac arteries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Iliac Artery Occlusive Disease, External Iliac Artery Occlusive Disease, Peripheral Arterial Disease
CountriesNew Zealand
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartDec 2013
Primary CompletionJan 2015
Study CompletionDec 2017
TodayJul 2026
First PostedOct 11, 2013
Enrollment StartDec 1, 2013
Primary CompletionJan 1, 2015
Study CompletionDec 14, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.7 years ago
Interventions
Stenting of common and/or external iliacsdevice
Balloon expandable stenting of iliac occlusive disease